Skip to main content
Figure 1 | Stem Cell Research & Therapy

Figure 1

From: Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives

Figure 1

Methods for cardiomyocyte differentiation of human pluripotent stem cells. bFGF, basic fibroblast growth factor; BMP4, bone morphogenetic protein-4; CM, cardiomyocyte; DKK1, Dickkopf homolog 1; dox, doxycycline; IWP, inhibitor of Wnt production; IWR1, inhibitor of Wnt response 1; KSR, knockout serum replacement; MEF, mouse embryonic fibroblast; mTESR, specialized stem cell culture medium; VEGF, vascular endothelial growth factor.

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512